Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
Mar 1, 2024, 18:24 |
Blog
A big thank you to all our panelists for Conversations on Cancer event - FDA Oncology
FDA Oncology recently shared a post on their X/Twitter page: ''A big thank you to all…
Feb 25, 2024, 14:57 |
Blog
Robert Francomano: Significant change in regulatory priorities by the FDA
Robert Francomano, Chief Commercial Officer at SELLAS, shared on LinkedIn: "The recent emphasis by the…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Feb 19, 2024, 17:05 |
Drugs
Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn: "Today, the FDA…
Feb 18, 2024, 15:35 |
Blog
OCE Project Socrates supported a variety of professional education resources in oncology/hematology - FDA Oncology
FDA Oncology recently shared a post on their X/Twitter page: "In 2023, OCE Project Socrates supported…
Feb 17, 2024, 16:27 |
Drugs
Tanja Obradovic: BioXcel Therapeutics received Fast Track designation by the FDA for BXCL701
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "Biotech companies…
Feb 17, 2024, 15:57 |
Insight
Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…
Feb 14, 2024, 18:13 |
Drugs
Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 - Oncology Brothers
Oncology Brothers made the following post on X: "Liposomal Irinotecan now FDA Oncology approved for…
Feb 12, 2024, 01:59 |
Blog
Al-Ola A Abdallah: Did the FDA Oncology make a big mistake by withdrawing Belantamab?
Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center,…
18
19
20
21
22
All:
938
Posts:
191 - 200
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube